These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1973642)

  • 1. Interplay between inotropic and lusitropic effects of cyclic adenosine monophosphate on the myocardial cell.
    Katz AM
    Circulation; 1990 Aug; 82(2 Suppl):I7-11. PubMed ID: 1973642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system.
    Katz AM; Tada M; Kirchberger MA
    Adv Cyclic Nucleotide Res; 1975; 5():453-72. PubMed ID: 165680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 3',5'-monophosphate, the myocardial cell membrane, and calcium.
    Wollenberger A; Will H; Krause EG; Wollenberger A; Will H; Krause EG
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():81-93. PubMed ID: 171710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cAMP: mechanism for positive inotropic action.
    Evans DB
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S22-9. PubMed ID: 2433539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative efficiency of beta adrenoceptor coupling to myocardial inotropy and diastolic relaxation: organ-selective treatment for diastolic dysfunction.
    Kenakin TP; Ambrose JR; Irving PE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1189-97. PubMed ID: 1675290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac contractility: modulation of myofibrillar calcium sensitivity by beta-adrenergic stimulation.
    Kögler H; Rüegg JC
    Isr J Med Sci; 1997 Jan; 33(1):1-7. PubMed ID: 9203510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclic AMP in myocardial cell function.
    Entman ML; Van Winkle WB
    Tex Rep Biol Med; 1979; 39():53-78. PubMed ID: 233324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance.
    Endoh M
    Eur J Pharmacol; 2004 Oct; 500(1-3):73-86. PubMed ID: 15464022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of phospholamban. A personal history.
    Katz AM
    Ann N Y Acad Sci; 1998 Sep; 853():9-19. PubMed ID: 10603932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Gilbert EM; Sandoval A; Rasmussen R; Cates AE; Feldman AM
    Circulation; 1990 Aug; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
    J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adrenertgic agonists on the cyclic AMP levels in atria from euthyroid and hypothyroid rats.
    Simpson WW; NcNeill JH
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):487-97. PubMed ID: 6106962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination of cardiac sarcoplasmic reticulum and myofibrillar function by protein phosphorylation.
    Kranias EG; Solaro RJ
    Fed Proc; 1983 Jan; 42(1):33-8. PubMed ID: 6293880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between inotropic response and cyclic AMP production induced by isoprenaline and forskolin in rat ventricle strips.
    Martinez E; Fuentes T; Collado MC; Hernández J
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):157-67. PubMed ID: 9226750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium transport systems in cardiac sarcolemma and their regulation by the second messengers cyclic AMP and calcium-calmodulin.
    Lamers JM
    Gen Physiol Biophys; 1985 Apr; 4(2):143-54. PubMed ID: 2993098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.